WealthSource Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,661
Closed -$425K 501
2023
Q1
$425K Buy
5,661
+88
+2% +$6.54K 0.03% 342
2022
Q4
$439K Buy
5,573
+920
+20% +$69K 0.03% 324
2022
Q3
$327K Buy
4,653
+442
+10% +$34.7K 0.02% 376
2022
Q2
$337K Sell
4,211
-291
-6% -$22.8K 0.02% 374
2022
Q1
$341K Buy
4,502
+197
+5% +$15.6K 0.02% 423
2021
Q4
$367K Sell
4,305
-934
-18% -$72.9K 0.03% 375
2021
Q3
$396K Buy
5,239
+799
+18% +$63.4K 0.03% 329
2021
Q2
$361K Buy
4,440
+920
+26% +$75.2K 0.03% 326
2021
Q1
$277K Buy
3,520
+978
+38% +$76.7K 0.03% 347
2020
Q4
$217K Sell
2,542
-1,882
-43% -$156K 0.03% 346
2020
Q3
$341K Buy
+4,424
New +$337K 0.05% 241

Other funds holding CL

WealthSource Partners's CL Position: Q2 2023 in Review

WealthSource Partners sold out of Colgate-Palmolive (CL) in Q2 2023, closing a stake of 5,661 shares — an estimated $425K sold.

WealthSource Partners first reported a position in CL in Q3 2020 and held it in 11 quarters. The position peaked at $439K in Q4 2022. 1,679 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • WealthSource Partners reported no remaining Colgate-Palmolive position as of Q2 2023 after selling out during the quarter.
  • WealthSource Partners sold 5,661 Colgate-Palmolive shares in Q2 2023, an estimated $425K.
  • WealthSource Partners first reported a position in Colgate-Palmolive in Q3 2020 and held it in 11 quarters.
  • WealthSource Partners's Colgate-Palmolive position peaked at $439K in Q4 2022.
  • 1,679 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on WealthSource Partners's 13F filing for Q2 2023, filed 15 Aug 2023.